Healthcare

Key data points: The market size in 2035 = $16.5 billion, growth forecast = 7.1% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in softgel capsules market to 2035 by type (gelatin/animal and non-animal), product type (prescription medicine and health & dairy suppliments), technology (antacid & anti-flatulent preparation, anti-anemic preparations, anti-inflammatory drugs, antibiotic & antibacterial drugs, cough & cold preparations, health supplement, vitamin & dietary supplement, and pregnancy), end use (pharmaceutical companies, nutraceutical companies, cosmeceutical companies, and contract manufacturing organizations), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2035 = $149 billion, growth forecast = 6.5% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in diabetes drug market to 2035 by installation type (above ground and under ground), material (metal, plastic, FRP, and others), application (industrial chemical waste, fuels, ordinary chemicals, and others), end use (petrochemical, paper & pulp, food & beverage, pharmaceuticals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities and forecast in the global medical aesthetic market to 2024 by product (facial aesthetic products, body contouring devices, cosmetic implants, hair removal devices, skin aesthetic devices, tattoo removal devices, thread lift products, physician-dispensed cosmeceuticals and skin lighteners, physician-dispensed eyelash products, and nail treatment laser devices), end user (clinics and medical spas, and beauty centers), and region (North America, Europe, Asia-Pacific, Rest of the World (ROW))

Trends, opportunities and forecast in the global mHealth solution market to 2024 by application (fitness and wellness, diabetes, cardiovascular diseases, central nervous system diseases, respiratory diseases, musculoskeletal diseases, smoking cessation, and medication adherence), product and services (mhealth applications, connected medical devices, and mhealth services), end user (public/private healthcare institutions, physicians, healthcare workers, and others), and region (North America, Europe, Asia-Pacific, and Rest of the World)

Trends, opportunities and forecast for the global stem cell therapy market from 2017 to 2028 by type (allogeneic stem cell therapy and autologous stem cell therapy), cell source (adipose tissue-derived MSCs (mesenchymal stem cells), bone marrow-derived MSCs, placental/umbilical cord-derived MSCs, and others), application (musculoskeletal disorders, wounds & injuries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 7.2% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global colon targeting drug delivery market to 2030 by type (pressure controlled drug-delivery systems, novel colon targeted delivery system (CODESTM), osmotic controlled drug delivery (ORDS-CT), and others), application (hospital, clinic, biology laboratory, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 11.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global biologics targeting ccr4 market to 2030 by type (monoclonal antibodies and small molecule chemicals), application (sezary syndrome and mycosis fungoides), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities, and forecast in the global telemedicine market to 2028 by component (product and services), product type (tele-hospital and tele-home), modality (store & forward, real-time, and others), delivery mode (web/mobile and call centers), application (teleradiology, telepsychiatry, telepathology, teledermatology, telecardiology and others), end use industry (providers, payers, patients, and others), and regions

Trends, opportunities and forecast in hydroxychloroquine market to 2025 by dosage type (200 mg, 400 mg, and 800 mg), sales channel (online and offline), application (COVID-19, malaria, rheumatoid arthritis, lupus erythematosus, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)

Key data points: The growth forecast = 10.3% annually for the next 7 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in long-acting drug delivery technology and service market to 2031 by material used (polymer based and non-polymer based), technique (injectables, hydrogels, implants, microneedles, and nanocrystal suspensions), dosage forms (long-acting injectables, long-acting implantable, topical / transdermal, vaginal, and others), distribution channels (hospitals & retail pharmacies, research & academics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $13.5 billion, growth forecast = 7.4% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global respiratory virus vaccine market to 2030 by type (inactivated/killed, live-attenuated, and recombinant), route of administration (intramuscular, intranasal, and subcutaneous), indication (influenza, measles, mumps & rubella, and coronavirus), end use (physician offices, hospitals, clinics, pharmacies/stores, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $256.13 billion, growth forecast = 5.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global otc drug & dietary supplement market to 2030 by dosage form (tablets, hard capsules, powders, ointments, soft capsules, liquids, and others), distribution channel (pharmacies, grocery stores, vitamin & health food stores, online pharmacy, and others), product (branded drugs and generic drugs), category (vitamin & dietary supplements, cough & cold products, analgesics, gastrointestinal products, sleep aids, otic products, wart removers, mouth care products, ophthalmic products, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $605.9 billion, growth forecast = 4.6% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global chlorpheniramine maleate market to 2030 by dosage form (tablets, syrup, and eye drops), application (allergy, hay fever (allergic rhinitis), common cold, watery eyes, itchy throat/skin, anaphylactic shock, and urticaria), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $17.1 billion, growth forecast = 12.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global heart failure drug market to 2030 by drug type (ace inhibitors, angiotensin receptor blockers, beta blockers, diuretics, and others), application (injection, capsule, and tablets), end use (hospitals, specialty centres, and others), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in autoimmune hepatitis diagnosis and treatment market to 2030 by type (type-i, type-ii, and variant AIH), diagnosis (blood test, imaging test, and liver biopsy), treatment (medication, corticosteroids, immune system suppressors, and liver transplant), end use industry (hospitals & clinics, diagnostic centre, and research institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World).type (type-I, type-II, and variant AIH), diagnosis (blood test, imaging test, and liver biopsy), treatment (medication, corticosteroids, immune system suppressors, and liver transplant), end use industry (hospitals & clinics, diagnostic centre, research institutions, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Trends, opportunities, and forecast for the global custom antibody market from 2017 to 2028 by service (antibody development, antigen preparation, immunization & hybridoma production, antibody characterization, antibody production & purification, and others), type (monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others), application (research and therapeutics), end use industry (pharmaceutical & biotechnological companies, academic & research institutes, and others), and region

Key data points: The market size in 2030 = $137.2 billion, growth forecast = 6.8% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global pain relief medication market to 2030 by drug class (nonsteroidal anti-inflammatory drugs, opioids, and others), distribution channel (hospital & retail pharmacies and online pharmacies), end use (cancer pain, neuropathic pain, musculoskeletal pain, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $3.6 billion, growth forecast = 7.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global allergy vaccine market to 2030 by type (subcutaneous immunotherapy and sublingual immunotherapy), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), application (allergic rhinitis, allergic asthma, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.5% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global opioid analgesic market to 2030 by drug class (morphine, codeine, fentanyl, meperidine, methadone, tramadol, oxycodone, dextromethorphan, buprenorphine, and others), indication (surgical pain, cancer pain, neuropathic pain, and others), route of administration (oral, parenteral, transdermal, and others), end use (hospital pharmacies, retail pharmacies, drug stores, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities and forecast in the global neurostimulation market to 2024 by product (spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and gastric electric stimulator), application (pain management, epilepsy, essential tremors, urinary and fecal incontinence, depression, dystonia, gastroparesis, parkinson’s disease, and others), end-user (hospitals, scientific research laboratories, and others), and region (North America, Europe, Asia-Pacific, Rest of the World (ROW)).

Key data points: The market size in 2030 = $6.9 billion, growth forecast = 18.6% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global malaria vaccine market to 2030 by type (pre-erythrocytic, erythrocytic, multi-antigen, and others), agent (plasmodium falciparum, plasmodium vivax, and anopheles species), end use (hospitals, specialty clinics, homecare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $4.8 billion, growth forecast = 6.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global companion animal vaccine market to 2030 by product type (attenuated live, conjugate, inactivated, subunit, toxoid, DNA, and recombinant), species type (canine, avian, feline, and equine), end use (hospitals & clinics, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in onychomycosis treatment market to 2030 by disease type (distal subungual onychomycosis, proximal subungual onychomycosis, white superficial onychomycosis, candidal onychomycosis, and others), treatment type (laser therapy, photodynamic therapy, and drug treatment), drug class (allylamine, azole, griseofulvin, and others), distribution channel (hospitals and clinics, online stores, retail pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunity and forecast in hyperhidrosis treatment market to 2028 by treatment type (botulinum toxin a, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands and others), hyperhidrosis type (axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis and others), distribution channel (hospital pharmacies, retail pharmacies and online pharmacies), end user (hospitals, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $4.6 billion, growth forecast = 5.8% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global chickenpox vaccine market to 2030 by product type (monovalent varicella vaccine and combination varicella vaccine), application (mumps, measles, rubella, varicella immunization, herpes zoster, immunization, and chickenpox vaccination), end use (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size growth forecast = 5.7% annually next 7 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global vaccine market to 2030 by technology (inactivated  vaccine, live attenuated vaccine, conjugate and subunit, toxoid vaccine, viral vector, mrna vaccine, and other technologies), product type (monovalent and multivalent), disease indication (covid-19, influenza, dtp, pneumococcal diseases, hpv, rotavirus, herpes zoster, varicella, and other disease indications), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $26.8 billion, growth forecast = 8.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global mrna vaccine market to 2030 by type (self-amplifying mRNA vaccines (SAM) and conventional non-amplifying mRNA vaccines), application (cancer immunotherapy, allergy tolerization, and therapeutic vaccines), end use (hospitals & clinics, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 7.0% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global remdesivir market to 2030 by dosage (2.5MG, 5MG, 100MG, and 200MG), form (lyophilized powder and concentrated solution), application (ebola, SARS-cov, and MERS-cov), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $1.2 billion, growth forecast = 4.4% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global rabies vaccine market to 2030 by product type (baby hamster kidney, purified chick embryo cell rabies vaccine, vero cell rabies vaccine, and others), vaccination type (pre-exposure vaccination (PEV) and post-exposure prophylaxis (PEP)), application (animal and human), end use (hospitals, homecare, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $2.2 billion, growth forecast = 8.7% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global avian influenza vaccine market to 2030 by strain type (H5, H9, H7, and others), type (inactivated, live attenuated, recombinant, vector-based, and others), application (chicken, duck, goose, turkey, quail, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities and forecast for the global cell dissociation market from 2017 to 2028 by product (enzymatic dissociation products, (collagenase, trypsin, papain, elastase, dnase, hyaluronidase, and other enzymes), non-enzymatic dissociation agents, and instruments & accessories), tissue type (connective tissues, epithelial tissues, and other tissues), application (tissue dissociation and cell detachment), end use industry (pharmaceutical and biotechnology companies, research and academics, and other end users), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $62.2 billion, growth forecast = 7.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global veterinary medication market to 2030 by product (drugs, vaccines, and medicated feed additives), route of administration (oral route, parenteral route, and topical route), distribution channel (veterinary hospitals pharmacies and retail veterinary pharmacies), animal type (companion animals and livestock animals), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities, and forecast for the global microcarrier market from 2017 to 2028 by product (consumables (media, reagents, and microcarrier), equipment (bioreactors, culture vessels , filtration and separation equipment, and cell counters)), application (biopharmaceutical production (vaccine production, therapeutic protein production), cell and gene therapy, tissue engineering and regenerative medicine), end use industry (pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, academic and research institutes, and cell banks), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 5.6% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global mtor inhibitor market to 2030 by product type (rapamune, afinitor, torisel, zortress, and others), indication (oncology, organ transplantation, immunosuppressant, and others), route of administration (oral, intravenous, and others), end use (hospitals, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $123.5 billion, growth forecast = 9.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global drug discovery technology market to 2030 by technology (high throughput screening, genomics, biochips, pharmacogenomics, bioanalytical instruments, bioinformatics, nanotechnology, and others), application (cardiovascular diseases, Parkinson's, Alzheimer's, and others), end use industry (pharmaceutical companies, biopharmaceutical companies, biotech companies, and research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $21.8 billion, growth forecast = 5.3% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global antidepressant market to 2030 by product (tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, serotonin antagonist & reuptake inhibitors, and others), depressive disorder (major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $1.1 billion, growth forecast = 12.1% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global dengue vaccine market to 2030 by type (live attenuated vaccine, chimeric live attenuated vaccine, inactivated vaccine, subunit vaccine, and nucleic acid based vaccine), treatment (diuretic, anti-allergic, blood thinners, and others), distribution channel (hospital pharmacy, online pharmacy, and retail pharmacy), end use (hospitals, homecare, specialty clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $113.1 billion, growth forecast = 4.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global preventive vaccine market to 2030 by type (live/attenuated vaccines, inactivated vaccines, toxoid vaccines, subunit vaccines, conjugate vaccines, dna vaccines, and recombinant vector vaccines), age group (adults and pediatrics), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $0.5 billion, growth forecast = 9.7% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global chikungunya vaccine market to 2030 by type (live-attenuated virus vaccines, inactivated viral vaccines, chimeric-alphavirus candidates, recombinant viral vaccines, and others), age group (paediatric, adult, and geriatric), end use (hospital pharmacies, retail pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2024 = $411 billion, growth forecast = 11.0% annually next 7 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global oncology drugs market to 2030 by type (chemotherapy, targeted therapy, immunotherapy , hormonal therapy, and others), application (blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, respiratory or lung cancer, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $1.8 billion, growth forecast = 5.6% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global tetanus toxoid vaccine market to 2030 by type (monovalent tetanus toxoid, tetanus-diphtheria, diphtheria, tetanus, & pertussis, and others), form (quadrivalent, pentavalent, and hexavalent), end use (hospitals & clinics, government organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $1.7 billion, growth forecast = 7.2% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global cat vaccine market to 2030 by technology (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines), age (below 6 months and above 6 months), distribution channel (veterinary clinics, pet stores, and online retailers), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 8.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global morphine market to 2030 by dosage form (injection, oral tablets, and others), distrbution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others), application (pain management, diarrhea suppressant, cold and cough suppressant, and others), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $1.59 billion, growth forecasts = 10.7% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global ashwagandha extract market to 2030 by form (powder, capsules/tablets, and others), distribution channel (business to business and business to consumer), application (sports nutrition, food and beverages, dietary supplements, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $168.7 million, growth forecast = 28.6% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global Ebola drug and vaccine market to 2030 by novel drug type (zmapp, favipiravir, gs-5734, tkm-Ebola, and avi-7537), vaccine type (cad3-zebov, rvsv-zebov, and others), strain type (zaire, sudan, tai forest, reston, and bundibugyo virus), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The growth forecast = 6.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global animal vaccine market to 2030 by product (attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and dna vaccines), animal type (companion animal , livestock animal , and aquaculture), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $245.0 million, growth forecast = 4.1% annually for the next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecasts in the global rubella vaccine market to 2030 by type (monovalent formulation, measles-rubella vaccine, measles, mumps, rubella vaccine, and measles mumps rubella varicella vaccine), end use (hospitals, NGO’s, pediatric clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Key data points: The market size in 2030 = $3.3 billion, growth forecast = 9.2% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global oropharyngeal cancer diagnosis and therapeutics market to 2030 by type (endoscopy, biopsy, imaging, MRI scan, CT scan, and pet-CT scan), treatment (surgery, chemotherapy, radiation therapy, targeted therapy, and others), end use (hospitals, ambulatory surgery centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)

Trends, opportunities and forecast in the global minimally invasive surgery market to 2024 by application (cosmetic surgery, cardiac surgery, gastrointestinal surgery, orthopedic surgery, and laparoscopic surgery and cryosurgery), product (handheld instruments, electrosurgical instruments, guiding devices, inflation system, and auxiliary instruments), technology (capsule endoscope, and medical robots), end user (government hospitals, private hospitals and surgical clinics, and academic and research institutes), and region region (North America, Europe, Asia-Pacific, Rest of the World (ROW))

Key data points: The market size in 2030 = $1.0 billion, growth forecast = 14.5% annually next 6 years. Scroll below to get more insights. This market report covers trends, opportunities, and forecast in the global typhoid fever vaccine market to 2030 by type (live attenuated vaccine, capsular polysaccharide vaccine, conjugate vaccine, and others), route of administration (oral and injection), end use (hospitals & clinics, specialty centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)